Biofrontera Inc. (BFRIW) stock
BFRIWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BFRI
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/30
$0.00+0.00 (0.00%)
Close on Oct 30, 2026Market cap $12.96MP/E –Yield –
Biofrontera price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Biofrontera's price to sales ratio was 0.2× on Oct 19, 2026, against 0.3× a year earlier. Over the last 5 years it ranged from 0.0× to 2.6×, with a median of 0.3×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 0.2× | +0.1 |
| 2025 | Dec 31, 2025 | 0.2× | −0.0 |
| 2024 | Dec 31, 2024 | 0.2× | +0.1 |
| 2023 | Dec 29, 2023 | 0.1× | −0.7 |
| 2022 | Dec 30, 2022 | 0.8× | −1.8 |
| 2021 | Dec 31, 2021 | 2.6× | – |